secwatch.observer — SEC 8-K summary
======================================

Issuer:     Charlotte's Web Holdings, Inc. (CWBHF)
CIK:        0001750155
Form:       8-K
Filed at:   2026-05-13T11:07:49+00:00
Accession:  0001750155-26-000076
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Charlotte's Web Q1 2026 revenue down 9% to $11.2M, net loss $13.1M, proposes BAT transaction to eliminate debenture
--------------------------------------------------------------------------------

- Revenue $11.2M vs $12.3M in Q1 2025; net loss includes $8.9M non-cash fair value charge on BAT convertible debenture.
- Proposed transaction with BAT to convert ~$54M debenture and invest $10M, eliminating $3M annual interest; shareholder vote May 28, 2026.
- CMS BEI program activated April 1, 2026, allowing hemp-derived CBD coverage up to $500/beneficiary; FDA issued limited enforcement discretion.
- Adjusted EBITDA improved to -$1.7M from -$2.8M; SG&A down 17.7% to $9.5M; OTCQX upgrade completed post-quarter.
- DeFloria Phase 2 trial for ASD irritability candidate AJA001 expected mid-2026; in-house gummy manufacturing substantially complete.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000076/0001750155-26-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000076/cweb-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001750155-26-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer